Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: The COVID-19 pandemic significantly disrupted healthcare systems worldwide, affecting the delivery of essential diagnostic services. HIV and HBV testing services, critical for the timely detection and management of these diseases, experienced substantial declines during the pandemic. This study aimed to assess the impact of the COVID-19 pandemic on HIV and HBV testing rates in western Iran.

Methods: We conducted an interrupted time series analysis using data on monthly HIV and HBV testing rates from Behavioral Health Counseling Centers in western Iran. The study period spanned from January 2017 to December 2023, divided into pre-pandemic (January 2017-December 2019) and pandemic (January 2020-December 2023) phases. We modeled the immediate level changes and trends in testing rates post-pandemic onset, accounting for pre-existing trends. Regression analysis provided estimates of changes in testing rates, with 95% confidence intervals (CI).

Results: The analysis revealed a significant decline in HIV testing rates, with an immediate reduction of 145.02 tests per month (95% CI: -159.78 to -130.26). A similar impact was observed for HBV testing, which decreased by 86.50 tests per month (95% CI: -95.51 to -77.49). While a recovery trend was observed for HIV testing over subsequent months, HBV testing exhibited a slower rebound. The disruptions were attributed to resource reallocation, movement restrictions, and reduced healthcare access during the pandemic.

Conclusion: The COVID-19 pandemic led to substantial disruptions in HIV and HBV diagnostic services in western Iran, underscoring the vulnerability of essential healthcare services to public health emergencies. Although recovery trends were observed, the slower rebound in HBV testing highlights the need for tailored interventions. Strengthening healthcare system resilience, ensuring resource allocation for routine diagnostics, and integrating pandemic preparedness into health policies are crucial to mitigating the impact of future crises.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12224574PMC
http://dx.doi.org/10.1186/s12889-025-23585-4DOI Listing

Publication Analysis

Top Keywords

hbv testing
24
testing rates
20
hiv hbv
16
western iran
12
covid-19 pandemic
12
testing
11
impact covid-19
8
interrupted time
8
time series
8
series analysis
8

Similar Publications

Colloidal gold technology in viral diagnostics: Recent innovations, clinical applications, and future perspectives.

Virology

September 2025

Xinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi, Xinjiang, China. Electronic address:

Colloidal gold technology has revolutionized viral diagnostics through its rapid, cost-effective, and user-friendly applications, particularly in point-of-care testing (POCT). This review synthesizes recent advancements, focusing on its role in detecting respiratory viruses, hepatitis viruses, and emerging pathogens. The technology leverages the unique optical and physicochemical properties of gold nanoparticles (AuNPs), including localized surface plasmon resonance (LSPR) and high surface-to-volume ratios, to achieve rapid antigen-antibody recognition with visual readouts within 15 min.

View Article and Find Full Text PDF

Hepatitis B virus (HBV) infection is a global health challenge, with the World Health Organization (WHO) targeting its elimination by 2030. Jordan lacks sufficient data on HBV epidemiology, including prevalence, incidence and clearance. This study addresses these gaps through a retrospective analysis of HBV testing data from 40,268 individuals collected at Biolab Diagnostic Laboratories (2010-2024).

View Article and Find Full Text PDF

Hepatitis B virus (HBV) infection is a serious public health concern worldwide, especially during pregnancy due to the associated health risks for the mother and fetus. This study aimed to explore the relationship between alanine aminotransferase (ALT) levels, age and HBV DNA levels in pregnant women with chronic HBV infection. Our cohort study included 1743 pregnant women with HBV who gave birth from January 2021 to June 2024.

View Article and Find Full Text PDF

The role of personal protective equipment (PPE) in protecting against exposure to infectious agents and toxic chemicals is well-established. However, the global surge in PPE demand during the pandemic exposed challenges, including shortages and environmental impacts from disposable waste. Developing effective, scalable, and sustainable decontamination methods for the reuse of PPE is essential.

View Article and Find Full Text PDF

Performance of the ELITe InGenius system for hepatitis B virus DNA quantification.

Diagn Microbiol Infect Dis

September 2025

French National Reference Center for Hepatitis B, C and delta Viruses, Department of Virology, Hôpital Henri Mondor, Créteil, France; INSERM U955, Créteil, France. Electronic address:

Measurement of hepatitis B virus (HBV) DNA levels is the standard of care for diagnosis active HBV infection, assessing disease severity and prognosis, and guiding treatment decisions and monitoring response to therapy. In the study, the analytical and clinical performance of the ELITe InGenius System for quantifying HBV DNA was evaluated. A total of 377 of archived EDTA plasma or serum specimens were tested.

View Article and Find Full Text PDF